Applications of 2-Chloro-N-Methoxy-N-Methylacetamide in Industrial Manufacturing

2-Chloro-N-Methoxy-N-Methylacetamide is a key chemical intermediate, produced at industrial scale for multiple specialized applications across the pharmaceutical, agrochemical, and fine chemical sectors. Our controlled synthesis process ensures strict batch uniformity, supporting consistent downstream formulation and manufacturing performance.

1. Pharmaceutical Intermediate in API Synthesis (e.g., Chloroacetamide Derivatives)

In pharmaceutical manufacturing, this compound functions as a vital building block in the synthesis of select active pharmaceutical ingredients, especially for certain anti-infective and anti-inflammatory APIs. Downstream process teams use this intermediate during nucleophilic substitution or amidation steps to introduce specific functional groups, particularly in the production of small-molecule therapies. The material’s purity, residual solvent profile, and isomeric consistency must meet strict GMP guidelines to ensure the safety and quality of the resulting drug substances. Quality assurance includes in-process controls as well as finished API release testing.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• Current Good Manufacturing Practices (cGMP) 21 CFR Parts 210/211 (U.S. FDA)
• EU Guidelines for GMP for Medicinal Products for Human and Veterinary Use (EudraLex Volume 4)

Typical usage ratio

• 0.7–1.3 molar equivalents per target API batch, with adjustment based on API synthesis route and process yield optimization

Downstream process integration

• Charged to reaction vessels during key amide formation, with controlled temperature and pH
• Reacts under monitored conditions with primary or secondary amines, forming target intermediates
• Accompanied by in situ purification or crystallization as per synthetic protocol

Final product types

• Antibiotic drug substances (e.g., cephalosporin analogs)
• Anti-inflammatory small molecule APIs
• Other specialty pharma intermediates

2. Key Intermediate for Agrochemical Synthesis

This compound supports the efficient production of select herbicide and pesticide molecules, especially in cases where its unique reactivity profile enables the introduction of functionalized amide side-chains. Agrochemical formulators depend on controlled material specifications—water content, assay, and low byproduct levels—to avoid interference with catalytic downstream steps. We deliver in quantities tailored to process-scale batch sizes, supporting continuous flow or batch reactor integration as required for plant protection chemical manufacturing.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• ISO 9001:2015 Quality Management System
• Product Stewardship under REACH (EU Registration, Evaluation, Authorisation and Restriction of Chemicals)

Typical usage ratio

• Up to 2.5% weight/weight relative to total batch mass for herbicide active ingredient synthesis, adjusted for molecular conversion efficiency

Downstream process integration

• Fed directly into amide coupling stages for the functionalization of agrochemical core scaffolds
• Blended with alkylating agents or nucleophiles under solvent-mediated conditions
• Residuals monitored and removed before formulation steps

Final product types

• Selective herbicide active ingredients
• Pre-emergent pesticide formulations
• Specialty crop protection intermediates

3. Fine Chemical Synthesis for Specialty Organic Reagents

In fine chemical manufacturing, this intermediate allows rapid construction of functionalized building blocks used for laboratory, diagnostic, and industrial analytical reagents. Downstream processes utilize the compound for controlled modification of carboxylic or amine group containing molecules, delivering high-yield transformation with minimal side-product formation. Quality specifications prioritize low heavy metal and halide content to maintain the integrity of analytical applications, requiring reliable batch consistency from the original raw material supply.

Industry compliance standards

• ISO 17034:2016 General requirements for the competence of reference material producers
• ISO 9001:2015 for Custom Synthesis
• Internal QC protocols for purity and trace contaminant assessment

Typical usage ratio

• Stoichiometric quantities (1.0–1.2 equivalents), adjusted according to desired conversion yield in laboratory syntheses

Downstream process integration

• Added during stepwise functional group introduction reactions under dry, inert conditions
• Product isolated by extraction and dried under vacuum
• QC sampling taken prior to shipment of finished reagent lots

Final product types

• Analytical organic reagents
• Custom laboratory intermediates
• Diagnostic chemical standards

4. Technology Platform for Contract Research & Custom Synthesis

Contract research organizations and custom synthesis partners use this intermediate as a customizable platform for route scouting and small-volume development of novel compounds. Process chemists can exploit its functional group reactivity for structural diversification or for kilo-lab scale-up studies, applying rigorous analytical controls to confirm identity, purity, and batch uniformity. The compliance focus remains on traceability, material handling, and consistent documentation for controlled transfer between manufacturing and R&D environments.

Industry compliance standards

• GLP (Good Laboratory Practice)
• ISO 9001:2015 for custom and contract synthesis
• Standard operating procedures for material traceability and change control

Typical usage ratio

• Scale ranges from gram to multi-kilogram, application-specific; typical ratios from 1.0 to 1.5 equivalents based on structure–activity relationship testing

Downstream process integration

• Weighing and addition at initial or subsequent synthetic step, depending on desired scaffold complexity
• Utilized in parallel or sequential library synthesis workflows
• Intermediates isolated and characterized by NMR, HPLC, or MS before proceeding

Final product types

• Lead compound libraries for medicinal chemistry
• Process intermediates for novel structure pilot trials
• Reference standards for chemical methodology validation